Duomeng Yang
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Receptor Mechanisms and Signaling 3
- Inflammasome and immune disorders 3
- Epidemiology 11
- Sepsis Diagnosis and Treatment 10
- Co-authors
- Baihai Jiao (4 shared papers)Ruijuan Liu (1 shared paper)Lili Qu (2 shared papers)Yongliang Yuan (1 shared paper)Hongmei Li (11 shared papers)Huadong Wang (10 shared papers)Xiuxiu Lv (9 shared papers)Yuan Wang (3 shared papers)
- Journals
- Shock (3 papers)International Immunopharmacology (3 papers)Biomedicine & Pharmacotherapy (2 papers)Communications Biology (2 papers)iScience (1 paper)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Duomeng Yang
26 papers receiving 446 citations
Duomeng Yang's Hit Papers
Peers
Comparison fields: 5 of 94
- Critical Care and Intensive Care Medicine 30
- Infectious Diseases 102
- Immunology 94
- Neurology 25
- Epidemiology 96
Countries citing papers authored by Duomeng Yang
This map shows the geographic impact of Duomeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duomeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duomeng Yang more than expected).
Fields of papers citing papers by Duomeng Yang
This network shows the impact of papers produced by Duomeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duomeng Yang. The network helps show where Duomeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Duomeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The development of COVID-19 treatment Hit paper breakdown → | 2023 | 133 |
| 2 | 2015 | 70 | |
| 3 | 2018 | 38 | |
| 4 | 2016 | 22 | |
| 5 | 2018 | 17 | |
| 6 | 2018 | 17 | |
| 7 | 2022 | 17 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 15 | |
| 10 | 2025 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2024 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2018 | 6 | |
| 19 | 2021 | 6 | |
| 20 | 2023 | 5 |
About Duomeng Yang
Duomeng Yang is a scholar working on Molecular Biology, Epidemiology, Immunology, Surgery and Pathology and Forensic Medicine, having authored 26 papers that have together received 450 indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (10 papers), interferon and immune responses (7 papers), Cardiac Ischemia and Reperfusion (5 papers), Intensive Care Unit Cognitive Disorders (4 papers), Receptor Mechanisms and Signaling (3 papers), Inflammasome and immune disorders (3 papers), Mosquito-borne diseases and control (3 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (30 citations), Infectious Diseases (102 citations), Immunology (94 citations), Neurology (25 citations) and Epidemiology (96 citations). Duomeng Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Baihai Jiao, Ruijuan Liu, Lili Qu, Yongliang Yuan, Hongmei Li, Huadong Wang, Xiuxiu Lv, Yuan Wang, Daxiang Lu and Xiaohui Yu. Their work appears in journals such as Shock, International Immunopharmacology, Biomedicine & Pharmacotherapy, Communications Biology and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.